Triethylene melamine in human malignant disease; results with oral administration of enteric-coated tablets.
D000284:Administration, Oral; D006689:Hodgkin Disease / Q000628:therapy*; D009369:Neoplasms / Q000628:therapy*; D013608:Tablets, Enteric-Coated; D014265:Triethylenemelamine / Q000627:therapeutic use*
D013608:Tablets, Enteric-Coated; D014265:Triethylenemelamine
HODGKIN'S DISEASE/therapy; NEOPLASMS/therapy; TRIETHYLENE MELAMINE/therapeutic use